Process for the preparation of thiazolidinedione derivatives
AssigneeSmithKline Beecham Corporation
InventorsRobert Gordon Giles, Norman John Lewis, John Kirby Quick
Life of this patent
Estimating the term…
Loading patent…
AssigneeSmithKline Beecham Corporation
InventorsRobert Gordon Giles, Norman John Lewis, John Kirby Quick
Estimating the term…
A process for preparing a compound of formula (I): or a tautomeric form thereof or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, wherein: A1 represents a substituted or unsubstituted aromatic heterocyclyl group; R1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; A2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6, which process comprises catalytically reducing a compound of formula (II): wherein A1, R1, A2 and n are as defined in relation to formula (I), characterised in that the reduction reaction is carried out using a hydrogen pressure above 20 psi; and thereafter if required forming a pharmaceutically acceptable salt and/or a pharmaceutically acceptable solvate of the compound of formula (I).
A process for preparing a compound selected from 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl}-2,4-thiazolidinedione, or a tautomeric form thereof, or a pharmaceutical acceptable salt thereof or a hydrate thereof, comprising
Dependencies are inferred from the claim text.